IMA vs SPGI · rev $9.2M vs P/E 27, rev $15.34B
ImageneBio, Inc. (IMA) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
IMA currently screens at market cap $64.7M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the IMA and SPGI stock pages for the full models.
Not investment advice.